Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
Stopped early · Not applicable
Conditions studied: Intermittent Exotropia
In brief
To determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old.
Key facts
- Study ID
- NCT02466659
- Run by
- Indiana University
- People needed
- 8
- Starts
- 2015-02-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2017-11-30
Who can join
Age: 3 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Intermittent exotropia (manifest deviation) meeting all of the following criteria:
- Intermittent exotropia at distance OR constant exotropia at distance and either intermittent exotropia or exophoria at near
- Exodeviation at least 15PD at distance OR near measured by prism and alternate cover test (PACT)
- Exodeviation at least 10PD at distance measured by PACT
- No previous surgical or non-surgical treatment for IXT (other than refractive correction)
- Visual acuity in the worse eye 0.3 logMAR or better (20/40 on ATS HOTV or 70 letters on E-ETDRS) for children ≥ 3 years of age
- No interocular difference of visual acuity more than 0.2 logMAR (2 lines on ATS HOTV or 10 letters on E-ETDRS) for children ≥ 7 years of age
- Investigator not planning to initiate amblyopia treatment
- No hyperopia greater than +3.50 D spherical equivalent in either eye
- No myopia greater than -6.00 D spherical equivalent in either eye
- No prior strabismus, intraocular, or refractive surgery
- No abnormality of the cornea, lens, or central retina
- Investigator willing to observe the IXT untreated for 3 years unless specific criteria for deterioration are met.
You may not qualify if…
- N/A
Where it is running
- Glick Eye Institute, Indiana University School of Medicine — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.